
Gene On Biotech is a leading CRO specializing in advanced Proteomics research services using Protein microarrays technology. The company accelerates bio R&D and drug development by providing high-density protein microarrays including 21,000 human protein microarrays and 200,000 peptide microarrays. Their platform enables rapid, high-throughput, and precise analysis of thousands of protein interactions and expressions in a single experiment, significantly reducing time and sample consumption compared to traditional methods. Gene On Biotech serves over 150 drug development clients and has contributed to 31 domestic drug projects and 2 drug approvals. Their services include antibody arrays, protein binding analysis, epitope mapping, and AI and quantum computing integration for next-generation drug candidate discovery and bioinformatics. The company is recognized for its world-class technology, cost-effective solutions, and customized full-service CRO offerings, partnering with pharmaceutical companies, biotech ventures, and academic researchers globally.

Gene On Biotech is a leading CRO specializing in advanced Proteomics research services using Protein microarrays technology. The company accelerates bio R&D and drug development by providing high-density protein microarrays including 21,000 human protein microarrays and 200,000 peptide microarrays. Their platform enables rapid, high-throughput, and precise analysis of thousands of protein interactions and expressions in a single experiment, significantly reducing time and sample consumption compared to traditional methods. Gene On Biotech serves over 150 drug development clients and has contributed to 31 domestic drug projects and 2 drug approvals. Their services include antibody arrays, protein binding analysis, epitope mapping, and AI and quantum computing integration for next-generation drug candidate discovery and bioinformatics. The company is recognized for its world-class technology, cost-effective solutions, and customized full-service CRO offerings, partnering with pharmaceutical companies, biotech ventures, and academic researchers globally.